REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 75 filers reported holding REPARE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $607,890 | +16.5% | 50,322 | +2.1% | 0.00% | – |
Q2 2023 | $521,637 | -15.7% | 49,304 | -21.6% | 0.00% | – |
Q1 2023 | $618,966 | -44.6% | 62,903 | -17.2% | 0.00% | – |
Q4 2022 | $1,117,768 | -37.4% | 75,987 | -48.4% | 0.00% | – |
Q3 2022 | $1,786,000 | -13.5% | 147,257 | -0.3% | 0.00% | – |
Q2 2022 | $2,065,000 | +75.0% | 147,691 | +78.0% | 0.00% | – |
Q1 2022 | $1,180,000 | +60.3% | 82,981 | +137.8% | 0.00% | – |
Q4 2021 | $736,000 | -67.9% | 34,890 | -60.1% | 0.00% | – |
Q3 2021 | $2,292,000 | -44.6% | 87,352 | -34.2% | 0.00% | -100.0% |
Q2 2021 | $4,138,000 | +115.3% | 132,728 | +112.0% | 0.00% | – |
Q1 2021 | $1,922,000 | +44.4% | 62,616 | +61.4% | 0.00% | – |
Q4 2020 | $1,331,000 | +100.8% | 38,796 | +80.2% | 0.00% | – |
Q3 2020 | $663,000 | +72.2% | 21,535 | +73.4% | 0.00% | – |
Q2 2020 | $385,000 | – | 12,421 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 2,560,703 | $78,588,000 | 15.73% |
MPM ASSET MANAGEMENT LLC | 2,603,089 | $79,889,000 | 15.43% |
MPM BioImpact LLC | 2,069,749 | $63,521,000 | 7.98% |
BVF INC/IL | 3,722,398 | $114,240,000 | 4.28% |
StepStone Group LP | 8,721 | $268,000 | 4.12% |
Logos Global Management LP | 900,000 | $27,621,000 | 2.70% |
Redmile Group, LLC | 2,665,496 | $81,804,000 | 1.15% |
Orbimed Advisors | 3,426,325 | $105,154,000 | 0.98% |
Soleus Capital Management, L.P. | 133,324 | $4,092,000 | 0.74% |
SPHERA FUNDS MANAGEMENT LTD. | 248,100 | $7,614,000 | 0.58% |